Radiation Quality and Workflow in NRG GY017: Anti-PD-L1 (Atezolizumab) as an Immune Primer or Concurrently With Radiation Therapy for Node-Positive Locally Advanced Cervical Cancer.
Int J Radiat Oncol Biol PhysMay 25, 2026 (epub)
Jyoti Mayadev, Wei Deng, Hayeon Kim et al.
✦ AI-curated · Sources linked
In 30 seconds
This randomized controlled trial evaluated the quality of pretreatment radiation therapy (RT) plans in patients with node-positive locally advanced cervical cancer receiving atezolizumab. Out of 37 reviewed plans, 35% were deemed major deviations requiring revision. The study highlights the importance of rigorous RT quality oversight in clinical trials.
Key findings
- 35% of submitted RT plans required major revisions to meet protocol standards.
- 11 deviations were related to bowel contours and 6 to nodal volumes.
- All patients achieved per-protocol scores prior to treatment administration.
Why it matters
Ensuring high-quality radiation therapy plans is crucial for patient safety and treatment efficacy in clinical trials. This study underscores the need for standardized quality oversight in advanced radiation techniques.